BBC — Bioshares Biotech Clinical Trials Fd

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the perfo...

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Industry

ETF

Exchange

AMEX

First trade date

2014-12-16

The interactive platform loads with JavaScript. Research tools are for informational purposes.